The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Diabetes Treatment — Bridging the Divide
Open accessAbstract
In the simplest terms, diabetes mellitus results when pancreatic beta cells are unable to maintain adequate insulin secretion to prevent hyperglycemia. A combination of genetic and environmental factors causes the underlying beta-cell failure. In type 1 diabetes, a T-cell–mediated autoimmune response against beta cells appears to be the main disease mechanism, whereas insulin resistance is the key metabolic abnormality in type 2 diabetes. Yet the way in which insulin resistance triggers beta-cell failure remains obscure. The report by Larsen et al. in this issue of the Journal (pages 1517–1526) provides insight into a shared mechanism of beta-cell dysfunction in type . . .
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Meier, J. J., Bhushan, A., Butler, A. E., Rizza, R. A., & Butler, P. C. (2005) · Diabetologia · doi:10.1007/s00125-005-1949-2 · Cited by 493
IL‐1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde?
Perrier, S., Darakhshan, F., & Hajduch, E. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.10.061 · Cited by 173
Ruiz, P. J., Masliah, E., Doherty, T. A., Quach, A., & Firestein, G. S. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.060541 · Cited by 24
Cited by
Advanced Glycation End Products and Diabetic Complications
Singh, V. P., Bali, A., Singh, N., & Jaggi, A. S. (2014) · The Korean Journal of Physiology & Pharmacology · doi:10.4196/kjpp.2014.18.1.1 · Cited by 1,518
Type 2 Diabetes Mellitus: A Review of Current Trends
Olokoba, A. B., Obateru, O. A., & Olokoba, L. B. (2012) · Oman Medical Journal · doi:10.5001/omj.2012.68 · Cited by 1,338
Oxidative stress in obesity: A critical component in human diseases
Marseglia, L., Manti, S., D’Angelo, G., Nicotera, A., Parisi, E., Di Rosa, G., Gitto, E., & Arrigo, T. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms16010378 · Cited by 933
Pharmacological significance of triazole scaffold
Kharb, R., Sharma, P. C., & Yar, M. S. (2011) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756360903524304 · Cited by 598
Experimental diabetes induced by alloxan and streptozotocin: The current state of the art
Radenković, M., Stojanović, M., & Prostran, M. (2016) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2015.11.004 · Cited by 270
Metadata
- Authors
- Rother, K. I.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-04-12
- Volume
- 356
- Issue
- 15
- Pages
- 1499-1501
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2021549782
- Cited by
- 370
- References
- 5
- FWCI
- 14.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diabetes Treatment — Bridging the Divide. https://app.cochat.ai/papers/10.1056/nejmp078030
- The paper
- Rother, K. I. (2007). Diabetes Treatment — Bridging the Divide. New England Journal of Medicine. https://doi.org/10.1056/nejmp078030
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.